Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer.
Basak EA, Koolen SLW, Hurkmans DP, Schreurs MWJ, Bins S, Oomen-de Hoop E, Wijkhuijs AJM, Besten ID, Sleijfer S, Debets R, van der Veldt AAM, Aerts JGJV, Mathijssen RHJ. Basak EA, et al. Among authors: schreurs mwj. Eur J Cancer. 2019 Mar;109:12-20. doi: 10.1016/j.ejca.2018.12.008. Epub 2019 Jan 14. Eur J Cancer. 2019. PMID: 30654225
Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets.
Bodewes ILA, van der Spek PJ, Leon LG, Wijkhuijs AJM, van Helden-Meeuwsen CG, Tas L, Schreurs MWJ, van Daele PLA, Katsikis PD, Versnel MA. Bodewes ILA, et al. Among authors: schreurs mwj. Front Immunol. 2019 Feb 26;10:312. doi: 10.3389/fimmu.2019.00312. eCollection 2019. Front Immunol. 2019. PMID: 30863411 Free PMC article.
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients.
Hurkmans DP, Basak EA, van Dijk T, Mercieca D, Schreurs MWJ, Wijkhuijs AJM, Bins S, Hoop EO, Debets R, Joerger M, Odink A, van der Veldt AAM, van der Leest CH, Aerts JGJV, Mathijssen RHJ, Koolen SLW. Hurkmans DP, et al. Among authors: schreurs mwj. J Immunother Cancer. 2019 Jul 19;7(1):192. doi: 10.1186/s40425-019-0669-y. J Immunother Cancer. 2019. PMID: 31324223 Free PMC article.
Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course.
Miedema J, Schreurs M, van der Sar-van der Brugge S, Paats M, Baart S, Bakker M, Hoek R, Dik WA, Endeman H, Van Der Velden V, van Gammeren A, Ermens A, Aerts JG, Thüsen JV. Miedema J, et al. Front Immunol. 2021 May 13;12:684142. doi: 10.3389/fimmu.2021.684142. eCollection 2021. Front Immunol. 2021. PMID: 34054876 Free PMC article.
Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors.
Hurkmans DP, Sassen SDT, de Joode K, Putter L, Basak EA, Wijkhuijs AJM, Joerger M, Debets R, Koch BCP, Van der Leest CH, Schreurs MWJ, van der Veldt AAM, Aerts JGJV, Mathijssen RHJ, Koolen SLW. Hurkmans DP, et al. Among authors: schreurs mwj. J Immunother Cancer. 2021 Jun;9(6):e002344. doi: 10.1136/jitc-2021-002344. J Immunother Cancer. 2021. PMID: 34088739 Free PMC article.
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Basak EA, Vermeer NS, de Joode K, Hurkmans DP, Velthuis DEM, Oomen-de Hoop E, Schreurs MWJ, Bins S, Koolen SLW, Debets R, van der Veldt AAM, Aerts JGJV, Joosse A, Mathijssen RHJ. Basak EA, et al. Among authors: schreurs mwj. Eur J Cancer. 2022 Oct;174:113-120. doi: 10.1016/j.ejca.2022.07.015. Epub 2022 Aug 19. Eur J Cancer. 2022. PMID: 35988409 Free article.
The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy.
Basak EA, de Joode K, Uyl TJJ, van der Wal R, Schreurs MWJ, van den Berg SAA, Oomen-de Hoop E, van der Leest CH, Chaker L, Feelders RA, van der Veldt AAM, Joosse A, Koolen SLW, Aerts JGJV, Mathijssen RHJ, Bins S. Basak EA, et al. Among authors: schreurs mwj. Biomed Pharmacother. 2022 Dec;156:113839. doi: 10.1016/j.biopha.2022.113839. Epub 2022 Oct 11. Biomed Pharmacother. 2022. PMID: 36228374 Free article.
Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report.
de Joode K, Veenbergen S, Kransse C, Kortleve D, Debets R, Mathijssen RHJ, Joosse A, Schreurs MWJ, Van der Veldt AAM. de Joode K, et al. Among authors: schreurs mwj. J Immunother Cancer. 2023 Feb;11(2):e006467. doi: 10.1136/jitc-2022-006467. J Immunother Cancer. 2023. PMID: 36750254 Free PMC article.
172 results